Answer
Its licence is for metastatic colorectal cancer already treated with available established therapies. The oncology team assesses previous treatment, cancer characteristics and suitability.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesemc · SmPC Current selected SmPC · Version 3